Michaela Scherr

7.1k citations

111 papers · 5.5k indexed · 2 hit papers · h-index 36

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Biological Psychiatry top 2%

Papers in

Hematology 29
- Chronic Myeloid Leukemia Treatments 17
- Acute Myeloid Leukemia Research 15
Cancer Research 23
- MicroRNA in disease regulation 15

Co-authors: Matthias Eder Karin Battmer Arnold Ganser Letizia Venturini Manuel Grez Denise Hilfiker‐Kleiner Karl Welte Axel Schambach
Journals: Blood (14 papers)Leukemia (8 papers)PLoS ONE (7 papers)Cardiovascular Research (5 papers)Gene Therapy (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Michaela Scherr

109 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy 2013 · 380 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Journal of Clinical Investigation
2006 Nature Medicine

Peers

Countries citing papers authored by Michaela Scherr

Since Specialization

Citations

This map shows the geographic impact of Michaela Scherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Scherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Scherr more than expected).

Fields of papers citing papers by Michaela Scherr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Scherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Scherr. The network helps show where Michaela Scherr may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michaela Scherr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michaela Scherr Line = papers co-authored together Michaela Scherr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia HemaSphere ·Asiyah Herrero, 주대현, Lisa Fleischer, Maurício de Souza Silveira, Ruth Esser, Steven R. Talbot, Axel Schambach, Ulrike Koehl, Olaf Heidenreich, Matthias Eder, Michaela Scherr	2025	0
2	Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages Cellular and Molecular Life Sciences ·L.M. Del-Caro, Franziska E. Müller, Lin Wang, 阿玲, Recreational Freshwater Fisheries Stakeholder Sub-Committee, Michaela Scherr, Christine S. Falk, Denise Hilfiker‐Kleiner, Melanie Ricke‐Hoch, Evgeni Ponimaskin	2025	3
3	XPO1-dependency of DEK::NUP214 leukemia Leukemia ·Taiwo Mercy, Arnold Kloos, Royston Landau, Yang Wei-guo, Robert Geffers, Asiyah Herrero, Leah Mitchell-Solomon, Kerstin Görlich, Sammantha B. Lane, Halyna R. Shcherbata, Michaela Scherr, Konstanze Döhner, Razif Gabdoulline, Michael Heuser	2025	0
4	Cardiomyocyte Notch1 signaling is essential for protection of the maternal heart from peripartum stress Cardiovascular Research ·Melanie Ricke‐Hoch, Britta Stapel, Jacqueline S. Harvey, Sergej Erschow, Michaela Scherr, Janika Viereck, Thomas Thum, Johann Bauersachs, Denise Hilfiker‐Kleiner	2024	2
5	Perhexiline Treatment Improves Toxic Effects of β-Adrenergic Receptor Stimulation in Experimental Peripartum Cardiomyopathy ESC Heart Failure ·Tobias J. Pfeffer, H. Moriya, Julia Müller, Michaela Scherr, Johann Bauersachs, Denise Hilfiker‐Kleiner, Melanie Ricke‐Hoch	2021	5
6	Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia Leukemia ·Arnold Kloos, Christine Vincenzetti, Samuel Dominguez Solis, Razif Gabdoulline, В Д Кассов, Nidhi Jyotsana, Leah Mitchell-Solomon, Renate Schottmann, Michaela Scherr, Charu Gupta, Felix F. Adams, Adrian Schwarzer, Dirk Heckl, Axel Schambach, Suzan Imren, R. Keith Humphries, Arnold Ganser, Felicitas Thol, Michael Heuser	2020	9
7	In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles Cardiovascular Research ·Melanie Ricke‐Hoch, Martijn F. Hoes, Tobias J. Pfeffer, Gagas A. Sasongko, Els C. van Wijk, Angelika Bartl, Nils Bömer, Michaela Scherr, Britta Stapel, Mai SAGAMI, Yulia Kiyan, Christine S. Falk, Arash Haghikia, Ofer Binah, Zoltàn Arany, Thomas Thum, Johann Bauersachs, Peter van der Meer, Denise Hilfiker‐Kleiner	2019	27
8	Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase PLoS ONE ·주대현, Victoria Emike Ologun, Iris Dallmann, Andreas Pich, Jan Hegermann, Arnold Ganser, Denise Hilfiker‐Kleiner, Olaf Heidenreich, Michaela Scherr, Matthias Eder	2019	3
9	miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo PLoS ONE ·I. A. Kucherkov, 주대현, Karin Battmer, Arnold Ganser, Denise Hilfiker‐Kleiner, Sascha David, Matthias Eder, Michaela Scherr	2018	3
10	NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia PLoS ONE ·Stefan Nagel, Claudia Pommerenke, Michaela Scherr, Corinna Meyer, Maren Kaufmann, Karin Battmer, Roderick A.F. MacLeod, Hans G. Drexler	2017	30
11	U-2932: two clones in one cell line, a tool for the study of clonal evolution Leukemia ·Hilmar Quentmeier, Rose‐Marie Amini, Malin Berglund, Wilhelm G. Dirks, Stefan Ehrentraut, Robert Geffers, Roderick A.F. MacLeod, Stefan Nagel, Julia Romani, Michaela Scherr, Margarete Zaborski, Hans G. Drexler	2012	19
12	Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies Cell stem cell ·Mélanie Hoch, Philipp Fischer, Britta Stapel, Ewa Missol‐Kolka, Belaïd Sekkali, Michaela Scherr, Fabrice Favret, Thomas Braun, Matthias Eder, Karin Schuster-Gossler, Achim Gossler, Andres Hilfiker, Jean‐Luc Balligand, Helmut Drexler, Denise Hilfiker‐Kleiner	2011	52
13	NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells BMC Cancer ·Stefan Nagel, Letizia Venturini, Grzegorz K. Przybylski, Piotr Grabarczyk, Corinna Meyer, Maren Kaufmann, Karin Battmer, Christian A. Schmidt, Hans G. Drexler, Michaela Scherr, Roderick A.F. MacLeod	2009	23
14	Lentiviral Vector-Mediated Expression of pre-miRNAs and AntagomiRs Methods in molecular biology ·Michaela Scherr, Letizia Venturini, Matthias Eder	2009	15
15	Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia Molecular Cancer ·Sonja Röhrs, Wilhelm G. Dirks, Claus Meyer, Rolf Marschalek, Michaela Scherr, Robert K. Slany, Andrew D. Wallace, Hans G. Drexler, Hilmar Quentmeier	2009	28
16	Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr–Abl transformed cells via the alteration of signaling complex and the receptor turnover Oncogene ·Alexandra Koch, Michaela Scherr, 尼博, Annalisa Mancini, Christian Kardinal, Karin Battmer, Matthias Eder, Teruko Tamura	2008	26
17	Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-Cell Acute Lymphoblastic Leukemia by Remote 3′- BCL11B Enhancers and Coregulation by PU.1 and HMGA1 Cancer Research ·Stefan Nagel, Michaela Scherr, Alexander Kel, Klaus Hornischer, Gregory E. Crawford, Maren Kaufmann, Corinna Meyer, Hans G. Drexler, Roderick A.F. MacLeod	2007	44
18	RNA‐Mediated Gene Silencing in Hematopoietic Cells BioMed Research International ·Letizia Venturini, Matthias Eder, Michaela Scherr	2006	6
19	A Novel Lentivirus Vector Derived from Apathogenic Simian Immunodeficiency Virus Virology ·Jörn Stitz, Michael D. Mühlebach, Ulrike Blömer, Michaela Scherr, Yuta Yokozaki, Белуцкий Игорь Юрьевич, MakotoOokawa, Oscar Santiago Ramírez Ruiz, Renate König, Matthias Schweizer, Klaus Cichutek	2001	24
20	Oligonucleotide Scanning of Native mRNAs in Extracts Predicts Intracellular Ribozyme Efficiency: Ribozyme-Mediated Reduction of the Murine DNA Methyltransferase Molecular Therapy ·Michaela Scherr, Michael R. Reed, 韩海雷, Arthur D. Riggs, John J. Rossi	2000	24

About Michaela Scherr

Michaela Scherr is a scholar working on Hematology, Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology, having authored 111 papers that have together received 5.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (26 papers), Chronic Myeloid Leukemia Treatments (17 papers), MicroRNA in disease regulation (15 papers), Acute Myeloid Leukemia Research (15 papers), Virus-based gene therapy research (13 papers), Advanced biosensing and bioanalysis techniques (13 papers), Acute Lymphoblastic Leukemia research (11 papers) and Cardiovascular Issues in Pregnancy (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Biological Psychiatry (169 citations), Neurology (520 citations), Hematology (585 citations) and Molecular Biology (3.3k citations). Michaela Scherr has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias Eder, Karin Battmer, Arnold Ganser, Letizia Venturini, Manuel Grez, Denise Hilfiker‐Kleiner, Karl Welte, Axel Schambach, Julia Skokowa and Christopher Baum. Their work appears in journals such as Blood, Leukemia, PLoS ONE, Cardiovascular Research and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact